Naringin attenuates Actinobacillus pleuropneumoniae-induced acute lung injury via MAPK/NF-κB and Keap1/Nrf2/HO-1 pathway

文献类型： 外文期刊

第一作者： Huang, Qi-Lin

作者： Huang, Qi-Lin;Liu, Chen;Pan, Xiang-Yi;Li, Zhao-Rong;Jing, Xiao-Han;Qiu, Zheng-Ying;Xin, Rui-Hua;Huang, Qi-Lin;Liu, Chen;Pan, Xiang-Yi;Li, Zhao-Rong;Jing, Xiao-Han;Qiu, Zheng-Ying;Xin, Rui-Hua;Huang, Qi-Lin;Liu, Chen;Pan, Xiang-Yi;Li, Zhao-Rong;Jing, Xiao-Han;Qiu, Zheng-Ying;Xin, Rui-Hua;Huang, Li-Na;Zhao, Guan-Yu

作者机构：

关键词： Actinobacillus pleuropneumoniae (APP); Naringin (NAR); Anti-inflammatory mechanism; Antioxidant mechanism

期刊名称：BMC VETERINARY RESEARCH （ 影响因子：2.6； 五年影响因子：2.9 ）

ISSN：

年卷期： 2024 年 20 卷 1 期

页码：

收录情况： SCI

摘要： Actinobacillus pleuropneumoniae (APP) causes porcine pleuropneumonia (PCP), which is clinically characterized by acute hemorrhagic, necrotizing pneumonia, and chronic fibrinous pneumonia. Although many measures have been taken to prevent the disease, prevention and control of the disease are becoming increasingly difficult due to the abundance of APP sera, weak vaccine cross-protection, and increasing antibiotic resistance in APP. Therefore, there is an urgent need to develop novel drugs against APP infection to prevent the spread of APP. Naringin (NAR) has been reported to have an excellent therapeutic effect on pulmonary diseases, but its therapeutic effect on lung injury caused by APP is not apparent. Our research has shown that NAR was able to alleviate APP-induced weight loss and quantity of food taken and reduce the number of WBCs and NEs in peripheral blood in mice; pathological tissue sections showed that NAR was able to prevent and control APP-induced pathological lung injury effectively; based on the establishment of an in vivo/in vitro model of APP inflammation, it was found that NAR was able to play an anti-inflammatory role through inhibiting the MAPK/NF-kappa B signaling pathway and exerting anti-inflammatory effects; additionally, NAR activating the Nrf2 signalling pathway, increasing the secretion of antioxidant enzymes Nqo1, CAT, and SOD1, inhibiting the secretion of oxidative damage factors NOS2 and COX2, and enhancing the antioxidant stress ability, thus playing an antioxidant role. In summary, NAR can relieve severe lung injury caused by APP by reducing excessive inflammatory response and improving antioxidant capacity.

分类号：

  • 相关文献
作者其他论文 更多>>

微信小程序